Cited by

• Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy.

  Kaburaki K, Sugino K, Sekiya M, Takai Y, Shibuya K, Homma S. Kaburaki K, et al. Intern Med. 2017;56(12):1563-1567. doi: 10.2169/internalmedicine.56.8055. Epub 2017 Jun 15. Intern Med. 2017. PMID: 28626185 Free PMC article.
• A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report.

  Itai M, Yamasue M, Takikawa S, Komiya K, Takeno Y, Igarashi Y, Takeshita Y, Hiramatsu K, Mitarai S, Kadota JI. Itai M, et al. BMC Pulm Med. 2021 Apr 7;21(1):115. doi: 10.1186/s12890-021-01475-w. BMC Pulm Med. 2021. PMID: 33827514 Free PMC article.
• Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

  Pérez-Jacoiste Asín MA, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Tejido Á, San Juan R, Arrebola-Pajares A, Lizasoain M, Prieto S, Aguado JM. Pérez-Jacoiste Asín MA, et al. Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119. Medicine (Baltimore). 2014. PMID: 25398060 Free PMC article. Review.
• Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.

  Choi CH, Lee SO, Smith G. Choi CH, et al. BMJ Case Rep. 2014 May 8;2014:bcr2013201202. doi: 10.1136/bcr-2013-201202. BMJ Case Rep. 2014. PMID: 24811557 Free PMC article.
• Systemic granulomatous reaction secondary to treatment of bladder cancer with bacillus calmette-guerin.

  Valentini CG, Bozzoli V, Larici AR, Larocca LM, Delogu G, Leone G, Pagano L. Valentini CG, et al. Mediterr J Hematol Infect Dis. 2012;4(1):e2012040. doi: 10.4084/MJHID.2012.040. Epub 2012 Jun 18. Mediterr J Hematol Infect Dis. 2012. PMID: 22811789 Free PMC article.